Cargando…

The roles and therapeutic potentialof mesenchymal stem/stromal cells and their extracellular vesicles in tendinopathies

Tendinopathies encompass a highly prevalent, multi-faceted spectrum of disorders, characterized by activity-related pain, compromised function, and propensity for an extended absence from sport and the workplace. The pathophysiology of tendinopathy continues to evolve. For decades, it has been relat...

Descripción completa

Detalles Bibliográficos
Autores principales: Quintero, Daniel, Perucca Orfei, Carlotta, Kaplan, Lee D., de Girolamo, Laura, Best, Thomas M., Kouroupis, Dimitrios
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9892947/
https://www.ncbi.nlm.nih.gov/pubmed/36741745
http://dx.doi.org/10.3389/fbioe.2023.1040762
_version_ 1784881420288655360
author Quintero, Daniel
Perucca Orfei, Carlotta
Kaplan, Lee D.
de Girolamo, Laura
Best, Thomas M.
Kouroupis, Dimitrios
author_facet Quintero, Daniel
Perucca Orfei, Carlotta
Kaplan, Lee D.
de Girolamo, Laura
Best, Thomas M.
Kouroupis, Dimitrios
author_sort Quintero, Daniel
collection PubMed
description Tendinopathies encompass a highly prevalent, multi-faceted spectrum of disorders, characterized by activity-related pain, compromised function, and propensity for an extended absence from sport and the workplace. The pathophysiology of tendinopathy continues to evolve. For decades, it has been related primarily to repetitive overload trauma but more recently, the onset of tendinopathy has been attributed to the tissue’s failed attempt to heal after subclinical inflammatory and immune challenges (failed healing model). Conventional tendinopathy management produces only short-term symptomatic relief and often results in incomplete repair or healing leading to compromised tendon function. For this reason, there has been increased effort to develop therapeutics to overcome the tissue’s failed healing response by targeting the cellular metaplasia and pro-inflammatory extra-cellular environment. On this basis, stem cell-based therapies have been proposed as an alternative therapeutic approach designed to modify the course of the various tendon pathologies. Mesenchymal stem/stromal cells (MSCs) are multipotent stem cells often referred to as “medicinal signaling cells” due to their immunomodulatory and anti-inflammatory properties that can produce a pro-regenerative microenvironment in pathological tendons. However, the adoption of MSCs into clinical practice has been limited by FDA regulations and perceived risk of adverse events upon infusion in vivo. The introduction of cell-free approaches, such as the extracellular vesicles of MSCs, has encouraged new perspectives for the treatment of tendinopathies, showing promising short-term results. In this article, we review the most recent advances in MSC-based and MSC-derived therapies for tendinopathies. Preclinical and clinical studies are included with comment on future directions of this rapidly developing therapeutic modality, including the importance of understanding tissue loading and its relationship to any treatment regimen.
format Online
Article
Text
id pubmed-9892947
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-98929472023-02-03 The roles and therapeutic potentialof mesenchymal stem/stromal cells and their extracellular vesicles in tendinopathies Quintero, Daniel Perucca Orfei, Carlotta Kaplan, Lee D. de Girolamo, Laura Best, Thomas M. Kouroupis, Dimitrios Front Bioeng Biotechnol Bioengineering and Biotechnology Tendinopathies encompass a highly prevalent, multi-faceted spectrum of disorders, characterized by activity-related pain, compromised function, and propensity for an extended absence from sport and the workplace. The pathophysiology of tendinopathy continues to evolve. For decades, it has been related primarily to repetitive overload trauma but more recently, the onset of tendinopathy has been attributed to the tissue’s failed attempt to heal after subclinical inflammatory and immune challenges (failed healing model). Conventional tendinopathy management produces only short-term symptomatic relief and often results in incomplete repair or healing leading to compromised tendon function. For this reason, there has been increased effort to develop therapeutics to overcome the tissue’s failed healing response by targeting the cellular metaplasia and pro-inflammatory extra-cellular environment. On this basis, stem cell-based therapies have been proposed as an alternative therapeutic approach designed to modify the course of the various tendon pathologies. Mesenchymal stem/stromal cells (MSCs) are multipotent stem cells often referred to as “medicinal signaling cells” due to their immunomodulatory and anti-inflammatory properties that can produce a pro-regenerative microenvironment in pathological tendons. However, the adoption of MSCs into clinical practice has been limited by FDA regulations and perceived risk of adverse events upon infusion in vivo. The introduction of cell-free approaches, such as the extracellular vesicles of MSCs, has encouraged new perspectives for the treatment of tendinopathies, showing promising short-term results. In this article, we review the most recent advances in MSC-based and MSC-derived therapies for tendinopathies. Preclinical and clinical studies are included with comment on future directions of this rapidly developing therapeutic modality, including the importance of understanding tissue loading and its relationship to any treatment regimen. Frontiers Media S.A. 2023-01-19 /pmc/articles/PMC9892947/ /pubmed/36741745 http://dx.doi.org/10.3389/fbioe.2023.1040762 Text en Copyright © 2023 Quintero, Perucca Orfei, Kaplan, de Girolamo, Best and Kouroupis. https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Bioengineering and Biotechnology
Quintero, Daniel
Perucca Orfei, Carlotta
Kaplan, Lee D.
de Girolamo, Laura
Best, Thomas M.
Kouroupis, Dimitrios
The roles and therapeutic potentialof mesenchymal stem/stromal cells and their extracellular vesicles in tendinopathies
title The roles and therapeutic potentialof mesenchymal stem/stromal cells and their extracellular vesicles in tendinopathies
title_full The roles and therapeutic potentialof mesenchymal stem/stromal cells and their extracellular vesicles in tendinopathies
title_fullStr The roles and therapeutic potentialof mesenchymal stem/stromal cells and their extracellular vesicles in tendinopathies
title_full_unstemmed The roles and therapeutic potentialof mesenchymal stem/stromal cells and their extracellular vesicles in tendinopathies
title_short The roles and therapeutic potentialof mesenchymal stem/stromal cells and their extracellular vesicles in tendinopathies
title_sort roles and therapeutic potentialof mesenchymal stem/stromal cells and their extracellular vesicles in tendinopathies
topic Bioengineering and Biotechnology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9892947/
https://www.ncbi.nlm.nih.gov/pubmed/36741745
http://dx.doi.org/10.3389/fbioe.2023.1040762
work_keys_str_mv AT quinterodaniel therolesandtherapeuticpotentialofmesenchymalstemstromalcellsandtheirextracellularvesiclesintendinopathies
AT peruccaorfeicarlotta therolesandtherapeuticpotentialofmesenchymalstemstromalcellsandtheirextracellularvesiclesintendinopathies
AT kaplanleed therolesandtherapeuticpotentialofmesenchymalstemstromalcellsandtheirextracellularvesiclesintendinopathies
AT degirolamolaura therolesandtherapeuticpotentialofmesenchymalstemstromalcellsandtheirextracellularvesiclesintendinopathies
AT bestthomasm therolesandtherapeuticpotentialofmesenchymalstemstromalcellsandtheirextracellularvesiclesintendinopathies
AT kouroupisdimitrios therolesandtherapeuticpotentialofmesenchymalstemstromalcellsandtheirextracellularvesiclesintendinopathies
AT quinterodaniel rolesandtherapeuticpotentialofmesenchymalstemstromalcellsandtheirextracellularvesiclesintendinopathies
AT peruccaorfeicarlotta rolesandtherapeuticpotentialofmesenchymalstemstromalcellsandtheirextracellularvesiclesintendinopathies
AT kaplanleed rolesandtherapeuticpotentialofmesenchymalstemstromalcellsandtheirextracellularvesiclesintendinopathies
AT degirolamolaura rolesandtherapeuticpotentialofmesenchymalstemstromalcellsandtheirextracellularvesiclesintendinopathies
AT bestthomasm rolesandtherapeuticpotentialofmesenchymalstemstromalcellsandtheirextracellularvesiclesintendinopathies
AT kouroupisdimitrios rolesandtherapeuticpotentialofmesenchymalstemstromalcellsandtheirextracellularvesiclesintendinopathies